Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Cytokine gene-modulated dendritic cells protect against allergic airway inflammation by inducing IL-10+IFN-γ+CD4+ T cells

Abstract

Asthma is characterized by allergen-induced airway inflammation orchestrated by Th2 cells. Dendritic cells (DCs) were found to efficiently prime naive T-helper cells. Thus, modification of DC function may be used as an ideal tool to treat allergic asthma by changing CD4+ T-cell differentiation or suppressing Th2 development. In this study, we examined whether a DC-based vaccine can be applied to DCs modified with interleukin (IL)-10- and IL-12-expressing adenoviruses to prevent ovalbumin (OVA)-induced asthma in mice. Herein, we show that these modified DCs efficiently moderated the characteristics of asthma, including expressions of OVA-specific antibodies, airway hyperresponsiveness, eosinophilic airway inflammation, and Th2 cytokines production. Additionally, IL-10 and IL-12 gene-modified DCs enhanced the development of both T-helper type 1 (Th1) and IL-10+IFN-γ+ (interferon-γ) double-positive T cells in vivo. In vitro-generated OVA-specific IL-10+IFN-γ+CD4+ T cells inhibited the proliferation of naive CD4+ T cells, and this suppressive effect was a cell contact-dependent mechanism. Furthermore, we showed that combined cytokine-modulated DCs could alleviate established allergic airway inflammation. Taken together, these results suggest that IL-10 and IL-12 gene-modulated DCs are effective in suppressing asthmatic airway inflammation through both immune deviation and immune suppression and are a potential therapeutic approach for asthma.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Azzawi M, Bradley B, Jeffery PK, Frew AJ, Wardlaw AJ, Knowles G et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990; 142: 1407–1413.

    Article  CAS  Google Scholar 

  2. Factor P . Gene therapy for asthma. Mol Ther 2003; 7: 148–152.

    Article  CAS  Google Scholar 

  3. Hansen G, Berry G, DeKruyff RH, Umetsu DT . Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999; 103: 175–183.

    Article  CAS  Google Scholar 

  4. Randolph DA, Carruthers CJ, Szabo SJ, Murphy KM, Chaplin DD . Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma. J Immunol 1999; 162: 2375–2383.

    CAS  PubMed  Google Scholar 

  5. Moser M, Murphy KM . Dendritic cell regulation of TH1-TH2 development. Nat Immunol 2000; 1: 199–205.

    Article  CAS  Google Scholar 

  6. Akbari O, Umetsu DT . Role of regulatory dendritic cells in allergy and asthma. Curr Allergy Asthma Rep 2005; 5: 56–61.

    Article  CAS  Google Scholar 

  7. Abbas AK, Murphy KM, Sher A . Functional diversity of helper T lymphocytes. Nature 1996; 383: 787–793.

    Article  CAS  Google Scholar 

  8. Borish L . IL-10: evolving concepts. J Allergy Clin Immunol 1998; 101: 293–297.

    Article  CAS  Google Scholar 

  9. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE . Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209–1220.

    Article  CAS  Google Scholar 

  10. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A . IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815–3822.

    CAS  PubMed  Google Scholar 

  11. Kasama T, Strieter RM, Lukacs NW, Burdick MD, Kunkel SL . Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol 1994; 152: 3559–3569.

    CAS  PubMed  Google Scholar 

  12. Takanaski S, Nonaka R, Xing Z, O’Byrne P, Dolovich J, Jordana M . Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med 1994; 180: 711–715.

    Article  CAS  Google Scholar 

  13. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M . Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151–1164.

    CAS  PubMed  Google Scholar 

  14. Groux H, O’Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737–742.

    Article  CAS  Google Scholar 

  15. Vieira PL, Christensen JR, Minaee S, O’Neill EJ, Barrat FJ, Boonstra A et al. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J Immunol 2004; 172: 5986–5993.

    Article  CAS  Google Scholar 

  16. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF et al. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002; 195: 603–616.

    Article  CAS  Google Scholar 

  17. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993; 177: 1199–1204.

    Article  CAS  Google Scholar 

  18. Wolf SF, Sieburth D, Sypek J . Interleukin 12: a key modulator of immune function. Stem Cells 1994; 12: 154–168.

    Article  CAS  Google Scholar 

  19. Gerosa F, Paganin C, Peritt D, Paiola F, Scupoli MT, Aste-Amezaga M et al. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-γ and interleukin-10. J Exp Med 1996; 183: 2559–2569.

    Article  CAS  Google Scholar 

  20. Chang HD, Radbruch A . The pro- and anti-inflammatory potential of interleukin-12. Ann NY Acad Sci 2007; 1109: 40–46.

    Article  CAS  Google Scholar 

  21. Trinchieri G . Regulatory role of T cells producing both interferon-γ and interleukin 10 in persistent infection. J Exp Med 2001; 194: F53–F57.

    Article  CAS  Google Scholar 

  22. Cosmi L, Santarlasci V, Angeli R, Liotta F, Maggi L, Frosali F et al. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-γ- and interleukin-10-production. Clin Exp Allergy 2006; 36: 261–272.

    Article  CAS  Google Scholar 

  23. Stock P, Akbari O, Berry G, Freeman GJ, Dekruyff RH, Umetsu DT . Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat Immunol 2004; 5: 1149–1156.

    Article  CAS  Google Scholar 

  24. Ye YL, Lee YL, Chuang ZJ, Lai HJ, Chen CC, Tao MH et al. Dendritic cells modulated by cytokine-expressing adenoviruses alleviate eosinophilia and airway hyperresponsiveness in an animal model of asthma. J Allergy Clin Immunol 2004; 114: 88–96.

    Article  CAS  Google Scholar 

  25. Kuipers H, Heirman C, Hijdra D, Muskens F, Willart M, van Meirvenne S et al. Dendritic cells retrovirally overexpressing IL-12 induce strong Th1 responses to inhaled antigen in the lung but fail to revert established Th2 sensitization. J Leukoc Biol 2004; 76: 1028–1038.

    Article  CAS  Google Scholar 

  26. Akbari O, DeKruyff RH, Umetsu DT . Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001; 2: 725–731.

    Article  CAS  Google Scholar 

  27. Zuany-Amorim C, Hailé S, Leduc D, Dumarey C, Huerre M, Vargaftig BB et al. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest 1995; 95: 2644–2651.

    Article  CAS  Google Scholar 

  28. Lee Y, Fu C, Chiang B . Administration of interleukin-12 exerts a therapeutic instead of a long-term preventive effect on mite Der p I allergen-induced animal model of airway inflammation. Immunology 1999; 97: 232–240.

    Article  CAS  Google Scholar 

  29. Hsu CY, Liu HE, Sheu FY, Leu SJ, Chiang BL, Hsiao G et al. Synergistic therapeutic effects of combined adenovirus-mediated interleukin-10 and interleukin-12 gene therapy on airway inflammation in asthmatic mice. J Gene Med 2010; 12: 11–21.

    Article  CAS  Google Scholar 

  30. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH . Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000; 192: 1213–1222.

    Article  CAS  Google Scholar 

  31. Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, Sharpe AH et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002; 8: 1024–1032.

    Article  CAS  Google Scholar 

  32. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E . Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361: 1869–1871.

    Article  Google Scholar 

  33. Batten M, Kljavin NM, Li J, Walter MJ, de Sauvage FJ, Ghilardi N . Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J Immunol 2008; 180: 2752–2756.

    Article  CAS  Google Scholar 

  34. Jankovic D, Kullberg MC, Feng CG, Goldszmid RS, Collazo CM, Wilson M et al. Conventional T-bet+Foxp3 Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 2007; 204: 273–283.

    Article  CAS  Google Scholar 

  35. Anderson CF, Oukka M, Kuchroo VJ, Sacks D . CD4+CD25Foxp3 Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 2007; 204: 285–297.

    Article  CAS  Google Scholar 

  36. Jankovic D, Kullberg MC, Hieny S, Caspar P, Collazo CM, Sher A . In the absence of IL-12, CD4+ T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10/− setting. Immunity 2002; 16: 429–439.

    Article  CAS  Google Scholar 

  37. Svetic A, Jian YC, Lu P, Finkelman FD, Gause WC . Brucella abortus induces a novel cytokine gene expression pattern characterized by elevated IL-10 and IFN-γ in CD4+ T cells. Int Immunol 1993; 5: 877–883.

    Article  CAS  Google Scholar 

  38. Gerosa F, Nisii C, Righetti S, Micciolo R, Marchesini M, Cazzadori A et al. CD4+ T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. Clin Immunol 1999; 92: 224–234.

    Article  CAS  Google Scholar 

  39. Lee YL, Ye YL, Yu CI, Wu YL, Lai YL, Ku PH et al. Construction of single-chain interleukin-12 DNA plasmid to treat airway hyperresponsiveness in an animal model of asthma. Hum Gene Ther 2001; 12: 2065–2079.

    Article  CAS  Google Scholar 

  40. Fu CL, Chuang YH, Huang HY, Chiang BL . Induction of IL-10 producing CD4+ T cells with regulatory activities by stimulation with IL-10 gene-modified bone marrow derived dendritic cells. Clin Exp Immunol 2008; 153: 258–268.

    Article  CAS  Google Scholar 

  41. Lee CC, Huang HY, Chiang BL . Lentiviral-mediated GATA-3 RNAi decreases allergic airway inflammation and hyperresponsiveness. Mol Ther 2008; 16: 60–65.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by grants from Cathay General Hospital (95 CGH-TMU-06) and from the National Science Council of the Republic of China (NSC95-2314-B-038-052).

Author information

Authors and Affiliations

Corresponding author

Correspondence to Y-L Lee.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on Gene Therapy website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hsu, CY., Leu, SJ., Chiang, BL. et al. Cytokine gene-modulated dendritic cells protect against allergic airway inflammation by inducing IL-10+IFN-γ+CD4+ T cells. Gene Ther 17, 1011–1021 (2010). https://doi.org/10.1038/gt.2010.39

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/gt.2010.39

Keywords

This article is cited by

Search

Quick links